ASCEND
BY NTHRYS

NTHRYSPhD AssistanceCancer Microbiology

Cancer Microbiology

Field
Category

Cancer Microbiology

Select a category to explore research frontiers

Cancer Microbiology200 categories·80 research gap frontiers·access £41
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
Microbial Oncogenesis and Carcinogenic Pathways
10 frontiers
10+
UIRGS
Investigation of bacterial and viral mechanisms that initiate malignant transformation through genotoxic and epigenetic alterations in host cells.
RESEARCH GAP FRONTIERS
Bacterial Metabolite-Driven Epithelial Transformation and MalignancyOncogenic Viral Integration Hotspots in Human CarcinogenesisMicrobial Lipopolysaccharide Signaling in Chronic Inflammation-Cancer Transition+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Helicobacter pylori Induced Gastric Cancer Biology
10 frontiers
10+
UIRGS
Mechanistic studies of H. pylori virulence factors and their role in chronic inflammation leading to gastric adenocarcinoma development.
RESEARCH GAP FRONTIERS
Bacterial Virulence Factors in Gastric Epithelial TransformationH. pylori-Driven Inflammatory Microenvironment and CarcinogenesisCagA Oncogene Integration and Chromosomal Instability Pathways+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Human Papillomavirus Cervical Oncogenic Transformation
10 frontiers
10+
UIRGS
Molecular analysis of HPV E6 and E7 oncoproteins in disrupting tumor suppressor pathways and promoting cervical cancer progression.
RESEARCH GAP FRONTIERS
Viral Oncoproteins and Chromatin Remodeling in Cervical TransformationHPV Persistence Mechanisms at the Epithelial-Immune BarrierMicrobiota-Mediated HPV Pathogenesis in Cervical Neoplasia+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Microbiota Dysbiosis and Colorectal Cancer Risk
10 frontiers
10+
UIRGS
Examination of altered bacterial composition and pathogenic strain enrichment in intestinal dysbiosis as drivers of colorectal carcinogenesis.
RESEARCH GAP FRONTIERS
Bacterial Metabolite Signaling in Colorectal CarcinogenesisDysbiotic Shifts and Intestinal Barrier Integrity LossOncogenic Pathogen-Host Immune Tolerance Mechanisms+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Hepatitis B Virus Chronic Infection Mechanisms
10 frontiers
10+
UIRGS
Analysis of HBV genome integration, chronic inflammation, and cirrhosis progression in hepatocellular carcinoma development pathways.
RESEARCH GAP FRONTIERS
HBV-Induced Epigenetic Remodeling in Hepatocellular CarcinomaViral Persistence Through Immunological Exhaustion and ToleranceHepatitis B Polymerase-Driven Genomic Instability Pathways+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Hepatitis C Virus Molecular Oncogenic Signaling
10 frontiers
10+
UIRGS
Study of HCV core and non-structural proteins in disrupting apoptosis, activating proliferation pathways, and promoting liver cancer.
RESEARCH GAP FRONTIERS
HCV Core Protein-Driven Metabolic Reprogramming in HepatocarcinogenesisNS5A-Mediated Disruption of Tumor Suppressor PathwaysViral-Induced Endoplasmic Reticulum Stress and Oncogenic Transformation+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Epstein Barr Virus Associated Lymphomagenesis
10 frontiers
10+
UIRGS
Investigation of EBV latent gene expression and immune evasion mechanisms in development of Burkitt and Hodgkin lymphomas.
RESEARCH GAP FRONTIERS
Latency Reversal and Clonal Expansion in EBV LymphomasViral miRNA-Host Oncogene Axis in LymphomagenesisImmune Escape Mechanisms in EBV-Driven B-Cell Malignancy+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Human Herpesvirus Eight Kaposi Sarcoma Pathogenesis
10 frontiers
10+
UIRGS
Elucidation of HHV8 viral oncogene homologs and inflammatory cytokine production in endothelial transformation and tumor progression.
RESEARCH GAP FRONTIERS
Latency Establishment and Viral Genome Persistence in Endothelial CellsKSHV-Induced Angiogenic Reprogramming and Vascular PermeabilityImmune Escape Through Viral Homologs of Regulatory Proteins+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Human T-cell Leukemia Virus Transformation Mechanisms
Analysis of HTLV-1 Tax and Rex proteins in deregulating cell cycle, apoptosis, and genomic instability in adult T-cell leukemia.
Explore frontiers →
Microbiome Immune Checkpoint Modulation in Cancer
Investigation of how commensal and pathogenic microbes regulate PD-1, CTLA-4 expression and influence immunotherapy response.
Explore frontiers →
Bacterial Metabolite Production and Tumor Growth
Study of short-chain fatty acids, trimethylamine, and secondary metabolites as immunomodulatory signals affecting cancer progression.
Explore frontiers →
Fusobacterium nucleatum Colorectal Cancer Pathogenesis
Mechanistic analysis of F. nucleatum adhesins, FadA and Fap2, in promoting tumor invasion, metastasis, and immunosuppression.
Explore frontiers →
Polyomavirus Carcinogenesis and Tumor Biology
Examination of merkel cell, JC, and BK polyomavirus T antigen oncoproteins in cellular transformation and cancer development.
Explore frontiers →
Microbial Lipopolysaccharide Signaling in Cancer
Investigation of bacterial LPS and TLR4 signaling in promoting chronic inflammation, angiogenesis, and tumor-promoting microenvironments.
Explore frontiers →
Microbiota-derived Tryptophan Metabolites and Cancer
Study of aryl hydrocarbon receptor ligands from microbial tryptophan metabolism in regulating intestinal barrier and tumor immunity.
Explore frontiers →
Bacterial Genotoxin Production and DNA Damage
Analysis of colibactin and cytolethal distending toxins in inducing double-strand breaks and chromosomal instability in cancer initiation.
Explore frontiers →
Porphyromonas gingivalis Oral Cancer Pathways
Investigation of oral pathogen-mediated chronic periodontitis, inflammation, and squamous cell carcinoma development mechanisms.
Explore frontiers →
Microbiota-derived Ligands in Aryl Hydrocarbon Receptor
Study of microbial production of AhR-activating metabolites in regulating epithelial barrier integrity and anti-tumor immunity.
Explore frontiers →
Viral Protein-Protein Interaction Network Mapping
Systematic proteomics analysis of oncogenic viral protein interactions with host tumor suppressors and cell cycle regulators.
Explore frontiers →
Microbial Exosome and Extracellular Vesicle Biology
Investigation of bacterial and viral extracellular vesicles in horizontal gene transfer, immune signaling, and tumor progression.
Explore frontiers →
Chronic Microbial Infection Immune Tolerance Mechanisms
Study of how persistent pathogens establish immune tolerance and regulatory T-cell populations that promote tumor development.
Explore frontiers →
Microbiome Composition and Chemotherapy Resistance
Analysis of specific bacterial taxa and their metabolic capabilities in modulating drug metabolism and chemotherapy efficacy.
Explore frontiers →
Viral Integration Hotspots and Cancer Genomics
Genomic characterization of viral insertion sites disrupting tumor suppressors and oncogenes in virus-associated malignancies.
Explore frontiers →
Microbial Dysbiosis Barrier Function and Cancer
Investigation of how pathogenic shifts impair intestinal tight junctions and increase bacterial translocation promoting systemic inflammation and malignancy.
Explore frontiers →
Papillomavirus Persistence Mechanisms and Cervical Cancer
Study of HPV immune evasion strategies, persistent infection establishment, and progression to invasive cervical carcinoma.
Explore frontiers →
Bacterial Lipid Antigen Presentation in Cancer Immunity
Analysis of CD1-restricted T cell responses to microbial glycolipids and their role in anti-tumor immunity regulation.
Explore frontiers →
Microbial Oncogenic Mutations and Selection Pressure
Investigation of how antibiotic selection pressure and treatment drives evolution of cancer-promoting bacterial variants.
Explore frontiers →
Viral miRNA Biogenesis and Oncogenic Function
Characterization of viral-encoded microRNAs in suppressing apoptosis, promoting proliferation, and modulating host immune responses.
Explore frontiers →
Merkel Cell Polyomavirus Immune Evasion Strategies
Study of MCPyV T antigen mechanisms in escaping cytotoxic T lymphocytes and natural killer cell recognition in skin cancer.
Explore frontiers →
Microbiota Butyrate Production and Tumor Suppression
Analysis of butyrate-producing bacteria, histone deacetylase inhibition, and enhanced anti-tumor immunity mechanisms.
Explore frontiers →
Bacterial Adhesins and Epithelial Cell Transformation
Study of how microbial adhesion molecules trigger signaling cascades leading to malignant cellular changes and cancer development.
Explore frontiers →
Oncogenic Virus Evolution in Immunocompromised Hosts
Investigation of accelerated viral evolution, mutation rates, and adaptation in immunosuppressed populations driving aggressive malignancies.
Explore frontiers →
Microbiota-dependent Systemic Inflammation and Cancer
Study of dysbiosis-driven elevation of circulating pro-inflammatory cytokines and systemic effects on tumor initiation and progression.
Explore frontiers →
Bacterial Arginine Metabolism and Immune Suppression
Analysis of microbial arginase production in depleting arginine, suppressing T cell function, and promoting immunosuppressive microenvironments.
Explore frontiers →
Hepatitis Delta Virus Coinfection and Cancer Risk
Investigation of HDV-HBV coinfection in accelerating liver fibrosis, cirrhosis, and hepatocellular carcinoma development pathways.
Explore frontiers →
Microbial Biofilm Formation in Tumor Microenvironment
Study of bacterial biofilm architecture, quorum sensing, and chemoresistance within tumors affecting cancer biology and treatment.
Explore frontiers →
Viral Long Non-coding RNA in Oncogenic Signaling
Characterization of viral-derived long non-coding RNAs in regulating oncogene expression and tumor suppressor silencing.
Explore frontiers →
Pyelonephritis-associated E. coli and Renal Cancer
Investigation of uropathogenic E. coli-driven chronic kidney infection and its association with renal cell carcinoma development.
Explore frontiers →
Microbiota Secondary Metabolite Xenobiotic Metabolism
Study of how microbial metabolic capacity influences carcinogen metabolism and bioavailability in cancer development.
Explore frontiers →
Oncogenic Coronavirus Spike Protein Evolution
Analysis of SARS-CoV-2 and other coronavirus variants in long-term immune dysregulation and potential cancer susceptibility.
Explore frontiers →
Bacterial Lipoteichoic Acid Immunomodulation Cancer
Investigation of gram-positive bacterial LTA signaling through TLR2 in promoting inflammation and tumor-permissive immune responses.
Explore frontiers →
Microbiota-dependent T Regulatory Cell Expansion
Study of specific bacterial strains in promoting Foxp3+ regulatory T cell differentiation and immune tolerance to tumors.
Explore frontiers →
Viral Oncogene Addiction in Cancer Cells
Examination of continued dependence on viral oncoproteins for transformed cell survival and therapeutic vulnerability exploitation.
Explore frontiers →
Microbiota Depletion and Immunotherapy Efficacy
Investigation of how broad-spectrum antibiotics impact microbiota composition and checkpoint inhibitor response in cancer patients.
Explore frontiers →
Bacterial Hyaluronidase and Tumor Invasion Promotion
Study of microbial enzyme production in degrading extracellular matrix components and facilitating cancer cell invasion and metastasis.
Explore frontiers →
Human Endogenous Retroviruses and Cancer Expression
Analysis of HERV reactivation in cancer cells, expression patterns, and potential immunogenic functions in anti-tumor immunity.
Explore frontiers →
Microbial Quorum Sensing and Carcinogenic Signaling
Investigation of bacterial density-dependent signaling in modulating virulence factor expression and cancer-promoting metabolite production.
Explore frontiers →
Oncogenic Virus Therapeutic Vaccination Development
Design and evaluation of therapeutic vaccines targeting virus-associated malignancies through enhanced cellular and humoral responses.
Explore frontiers →
Microbiota Succession Dynamics in Cancer Development
Temporal analysis of microbial community assembly, species replacement, and ecological shifts driving carcinogenic progression.
Explore frontiers →
Bacterial Flagellin Innate Immunity Cancer Promotion
Study of TLR5-flagellin signaling in promoting TH17 differentiation and IL-17-mediated tumor-promoting inflammation.
Explore frontiers →
Streptococcus bovis Bacteremia and Colorectal Neoplasia
Investigation of S. bovis endocarditis as a clinical marker and potential etiologic agent in colorectal adenoma and carcinoma development through molecular pathogenesis studies.
Explore frontiers →
Clostridium difficile Toxin-mediated Intestinal Barrier Disruption
Examination of C. difficile toxins in compromising intestinal epithelial integrity and promoting cancer-associated inflammatory responses in the colon.
Explore frontiers →
Prevotella copri Immune Dysregulation and Cancer Susceptibility
Study of P. copri metabolic byproducts and immune-modulating effects that increase systemic inflammation and cancer development risk.
Explore frontiers →
Mycobacterium tuberculosis Chronic Granulomatous Inflammation
Analysis of persistent mycobacterial infection-induced granuloma formation as a chronic inflammatory microenvironment promoting lung and lymphoid malignancies.
Explore frontiers →
Chlamydia trachomatis Ocular and Urogenital Carcinogenesis
Investigation of C. trachomatis chronic infection mechanisms in inducing squamous cell carcinoma of the eye and urogenital tract tissues.
Explore frontiers →
Mycoplasma pneumoniae Persistent Infection and Lymphoma
Characterization of mycoplasmal antigens and superantigen-like properties driving chronic T-cell activation and lymphoproliferative disorder development.
Explore frontiers →
Enterococcus faecalis Biofilm-associated Carcinogenic Signaling
Study of enterococcal biofilm-resident bacteria producing cytolysin and genotoxins that promote intestinal epithelial transformation and adenocarcinoma progression.
Explore frontiers →
Papillomavirus L1 Capsid Protein Immune Tolerance Induction
Mechanistic investigation of how HPV structural proteins evade innate immunity and establish persistent infection enabling malignant progression.
Explore frontiers →
Rotavirus NSP4 Enterotoxin and Intestinal Barrier Function
Analysis of rotavirus nonstructural protein-induced secretory diarrhea mechanisms that alter microbiota composition and cancer risk factors.
Explore frontiers →
Acinetobacter baumannii Lipopolysaccharide Tumor-promoting Inflammation
Investigation of multidrug-resistant A. baumannii LPS in driving persistent innate immune activation and tumor-promoting inflammatory responses.
Explore frontiers →
Candida albicans Commensal-pathogenic Transition and Cancer
Study of fungal morphological switching and immune dysregulation during C. albicans overgrowth promoting oncogenic inflammation and carcinogenesis.
Explore frontiers →
Aspergillus fumigatus Allergic Airway Inflammation Pathway
Examination of A. fumigatus spore and metabolite-induced chronic allergic responses creating a microenvironment permissive for lung cancer development.
Explore frontiers →
Pneumocystis jirovecii Immune Reconstitution Inflammatory Syndrome
Investigation of opportunistic pneumocystis infection-induced inflammatory immune responses in immunocompromised hosts and malignancy risk.
Explore frontiers →
Viral Oncogene-host Cell Epigenetic Reprogramming Mechanisms
Comprehensive study of how viral oncoproteins alter chromatin landscape and DNA methylation patterns to establish transcriptional programs favoring transformation.
Explore frontiers →
Microbiota-derived Phenolic Metabolite Aromaticity and Cancer
Analysis of bacterial conversion of dietary polyphenols into bioavailable ligands affecting xenobiotic metabolism and cancer drug efficacy.
Explore frontiers →
Tumor-associated Microbiota Niche Partitioning and Competition
Investigation of ecological dynamics and metabolic interdependencies among microbial consortia within tumor tissues during cancer progression.
Explore frontiers →
Viral Protease Cleavage of Tumor Suppressor Proteins
Mechanistic characterization of viral serine and cysteine proteases targeting p53, Rb, and other critical tumor suppressors for functional inactivation.
Explore frontiers →
Bacterial Cyclopropane Fatty Acid Immune Evasion Properties
Study of cyclopropane modifications in bacterial lipids reducing recognition by pattern recognition receptors and dampening anticancer immunity.
Explore frontiers →
Oncogenic Virus Transcriptional Hijacking of Cellular Machinery
Investigation of viral mechanisms commandeering host RNA polymerase and transcription factors to reprogram cellular gene expression toward transformation.
Explore frontiers →
Microbiota-modulated Intestinal Permeability and Cancer Metastasis
Analysis of how dysbiotic microbiota reduce tight junction protein expression and increase bacterial translocation promoting systemic inflammation and metastatic dissemination.
Explore frontiers →
Human Papillomavirus E6-p53 Binding Domain Structural Dynamics
Structural and biochemical characterization of HPV E6 oncoproteins'' interaction interfaces with p53 and ubiquitin ligase complexes enabling protein degradation.
Explore frontiers →
Bacterial Genotoxic Polyketides and Chromosomal Instability
Investigation of secondary metabolites from pathogenic bacteria like Serratia and Salmonella causing DNA double-strand breaks and aneuploidy in epithelial cells.
Explore frontiers →
Viral miRNA Processing and Host mRNA Silencing Networks
Comprehensive mapping of viral-encoded microRNAs that suppress antitumor immunity genes and promote cellular survival pathways in infected cells.
Explore frontiers →
Microbiota Vitamin B12 Synthesis and Homocysteine Metabolism
Study of how dysbiosis impairs microbial B12 production affecting homocysteine metabolism and promoting endothelial dysfunction and cancer development.
Explore frontiers →
Oncogenic Virus RNA Secondary Structure Immune Recognition
Investigation of viral RNA stem-loop and pseudoknot structures evading innate sensors like RIG-I and MDA5 to establish persistent infection.
Explore frontiers →
Bacterial Lipid A Endotoxin Dose-dependent Cancer Promotion
Characterization of lipopolysaccharide concentration-dependent effects on TLR4 signaling and transition from protective immunity to pro-tumoral inflammation.
Explore frontiers →
Microbiota-derived Secondary Bile Acid Receptor Signaling
Analysis of bacterial bile salt hydrolase activity and farnesoid X receptor activation pathways modulating intestinal immunity and cancer susceptibility.
Explore frontiers →
Viral DNA Methylation Patterns and Epigenetic Memory
Study of viral genome methylation dynamics and maintenance across infection cycles establishing heritable transcriptional reprogramming of cancer-promoting genes.
Explore frontiers →
Polymicrobial Infection Synergy in Tumor Microenvironment
Investigation of cooperative pathogenic mechanisms when multiple bacteria or viruses coexist within tumors amplifying carcinogenic signaling and immune evasion.
Explore frontiers →
Bacterial Siderophore-mediated Iron Acquisition and Oncogenic Signaling
Study of how bacterial iron-chelating compounds modulate bioavailability affecting oxidative stress responses and transcription factors in transformed cells.
Explore frontiers →
Viral Glycoprotein Masking and Antibody Evasion Epitopes
Characterization of N-linked and O-linked glycosylation patterns on viral surface proteins that shield epitopes and reduce neutralizing antibody recognition.
Explore frontiers →
Fusobacterium nucleatum Adhesin FadA-integrin Signaling Axis
Mechanistic study of FadA protein binding to E-cadherin and integrins activating Wnt-beta-catenin pathways in colorectal epithelial transformation.
Explore frontiers →
Microbiota Estrobolome and Estrogen-receptor Cancer Pathways
Investigation of bacterial beta-glucuronidase activity in estrogen recirculation and estrogen receptor signaling in hormone-responsive cancers.
Explore frontiers →
Oncogenic Herpesvirus Nucleotide Metabolism Reprogramming
Analysis of viral encoded enzymes like thymidine kinase and ribonucleotide reductase driving nucleotide pool expansion supporting viral replication and genomic instability.
Explore frontiers →
Bacterial Mucinolytic Enzyme Activity and Barrier Dysfunction
Study of glycoside hydrolases from Akkermansia and other bacteria degrading protective mucin layers and promoting pathogenic translocation.
Explore frontiers →
Viral Immune Checkpoint Ligand Expression and T Cell Exhaustion
Investigation of viral proteins upregulating PD-L1 and LAG-3 ligands on infected cells creating an immunosuppressive microenvironment permissive for transformation.
Explore frontiers →
Microbiota-derived Oxalate Metabolism and Systemic Toxicity
Analysis of bacterial oxalate production and degradation affecting mineral absorption and chronic inflammation linked to cancer development.
Explore frontiers →
Viral Integration-driven Enhancer Activation and Oncogene Dysregulation
Mechanistic characterization of how viral genome insertion into regulatory regions provides strong promoters for adjacent proto-oncogene transcriptional activation.
Explore frontiers →
Bacterial Collagenase and Metalloproteinase-mediated Stroma Invasion
Study of clostridial collagenase and Serratia metalloproteinases degrading extracellular matrix proteins facilitating tumor cell invasiveness and dissemination.
Explore frontiers →
Microbiota Short-chain Fatty Acid Histone Deacetylase Inhibition
Investigation of butyrate and propionate as natural HDAC inhibitors modulating chromatin accessibility and tumor suppressor gene expression in intestinal epithelium.
Explore frontiers →
Viral Replication Organelle Architecture and Immune Evasion
Structural study of membranous compartments created by oncogenic viruses sequestering viral replication away from pattern recognition receptor detection.
Explore frontiers →
Bacterial Exotoxin-mediated Cell Death Resistance Mutations
Investigation of how chronic low-level toxin exposure selects for epithelial cell variants with altered apoptosis pathways increasing transformation potential.
Explore frontiers →
Microbiota Lipid A Structural Variation and TLR4 Tolerance
Study of altered lipid A structures in commensal bacteria reducing TLR4 signaling and dampening innate immune responses critical for cancer prevention.
Explore frontiers →
Oncogenic Virus Circular RNA Biogenesis and Exon-skipping
Characterization of viral-induced alternative splicing generating circular RNAs acting as oncogenic microRNA sponges and translation regulators.
Explore frontiers →
Fungal Ergot Alkaloid Production and Neuroendocrine Signaling
Investigation of ergotamine and lysergic acid produced by fungal contaminants affecting serotonergic pathways and immune-neuroendocrine axis in cancer risk.
Explore frontiers →
Bacterial Nitroso Metabolite Synthesis and Nitrosative Stress
Study of bacterial nitrite reduction producing nitric oxide and reactive nitrogen species causing DNA damage and mutagenesis in epithelial tissues.
Explore frontiers →
Viral Protein-RNA Binding Networks and Codon Adaptation
Comprehensive mapping of viral RNA-binding proteins controlling mRNA stability and translation efficiency optimized for transformed cellular metabolism.
Explore frontiers →
Microbiota-mediated Antimicrobial Peptide Suppression and Dysbiosis
Investigation of how pathogenic microbiota reduce secretion of intestinal antimicrobial peptides like lysozyme and defensins enabling pathogenic overgrowth.
Explore frontiers →
Oncogenic Virus Mitochondrial Membrane Disruption and Apoptosis Evasion
Mechanistic analysis of viral proteins blocking mitochondrial outer membrane permeabilization through BCL-2 family protein manipulation preventing cancer cell death.
Explore frontiers →
Bacterial Urease-mediated Ammonia Production and pH Alkalinization
Study of ureolytic bacteria creating alkaline microenvironments that promote epithelial cell transformation and selecting for acid-resistant cancer cells.
Explore frontiers →
Microbial Extracellular DNA and Oncogenic Transformation
Investigation of how bacterial and viral extracellular DNA mediates horizontal gene transfer and promotes malignant cellular transformation through integrative mechanisms.
Explore frontiers →
Microbial-derived Short Chain Fatty Acids and Cancer
Study of how bacterial fermentation products regulate histone deacetylase inhibition and epigenetic modification in cancer prevention and treatment.
Explore frontiers →
Viral Oncoproteins and Ubiquitin Proteasome System
Analysis of how oncogenic viral proteins manipulate cellular ubiquitination pathways to disrupt tumor suppressor protein degradation and stability.
Explore frontiers →
Methanobrevibacter smithii and Metabolic Reprogramming
Characterization of archaeal metabolite-mediated rewiring of cancer cell glucose and lipid metabolism through cross-domain microbial signaling.
Explore frontiers →
Clostridium difficile Toxins and Intestinal Barrier Integrity
Investigation of bacterial exotoxin-induced disruption of epithelial tight junctions and enhanced cancer cell invasiveness through barrier dysfunction.
Explore frontiers →
Human Papillomavirus E6 and E7 Protein Complexomes
Systematic mapping of viral oncoproteins'' interactomes and their dynamic rewiring of p53 and retinoblastoma tumor suppressor pathways.
Explore frontiers →
Microbial Lipid A Endotoxemia and Cancer Progression
Study of gram-negative bacterial lipid A translocation across compromised epithelial barriers and its role in systemic immune activation and metastasis.
Explore frontiers →
Tumor-Associated Virome Deep Sequencing and Characterization
Comprehensive metaviromic profiling of viral populations within solid tumors and identification of novel oncogenic pathogenic mechanisms.
Explore frontiers →
Bacterial Siderophore Production and Iron Metabolism Cancer
Examination of how microbial iron sequestration and siderophore-mediated iron acquisition influence tumor iron homeostasis and ferroptosis resistance.
Explore frontiers →
Cytomegalovirus and Glioblastoma Multiforme Coinfection
Investigation of human cytomegalovirus reactivation in glioblastoma tissues and its contribution to tumor immunosuppression and treatment resistance.
Explore frontiers →
Microbial Zonula Occludens Toxin and Cancer Permeability
Analysis of bacterial tight junction-disrupting toxins'' effects on tumor epithelial permeability and enhanced metastatic dissemination.
Explore frontiers →
Oral Microbiota and Pancreatic Cancer Risk Stratification
Identification of oral microbial dysbiosis signatures predictive of pancreatic adenocarcinoma development and prognosis through longitudinal cohort analysis.
Explore frontiers →
Viral Circular RNA and Oncogenic Gene Regulation
Discovery and mechanistic characterization of viral-derived circular RNAs functioning as competing endogenous RNAs and miRNA sponges in cancer cells.
Explore frontiers →
Bacterial Colibactin and DNA Crosslink Mutagenesis
Structural and biochemical study of polyketide-nonribosomal peptide hybrid colibactin toxin-induced interstrand DNA crosslinks and malignant transformation.
Explore frontiers →
Skin Microbiota and Melanoma Immunotherapy Response
Characterization of cutaneous commensal bacterial composition as biomarker predicting checkpoint inhibitor efficacy in melanoma patients.
Explore frontiers →
Mumps Paramyxovirus and Pancreatic Tumorigenesis
Investigation of mumps virus-induced chronic pancreatitis as predisposing factor for pancreatic ductal adenocarcinoma development.
Explore frontiers →
Microbial Lipopeptides and TLR2 Signaling in Cancer
Examination of bacterial lipopeptide-mediated toll-like receptor 2 activation in promoting myeloid-derived suppressor cell differentiation and tumor immunoevasion.
Explore frontiers →
Tumor Microenvironment Viral-Bacterial Synergism Studies
Investigation of cooperative pathogenic interactions between tumor-resident viruses and bacteria amplifying oncogenic signaling and immune suppression.
Explore frontiers →
Lactobacillus acidophilus Polysaccharides and Immune Licensing
Study of commensal lactic acid bacterial cell wall polysaccharides driving intestinal T cell tolerance and cancer immunotherapy resistance.
Explore frontiers →
JC Polyomavirus T Antigen and Astrocytoma Oncogenesis
Characterization of JC virus large T antigen-mediated transformation of astrocyte progenitors and progressive brain tumor development.
Explore frontiers →
Microbial Secondary Bile Acid Metabolism and Cancer
Analysis of bacterial bile salt hydrolase activity and secondary bile acid-mediated farnesoid X receptor and TGR5 signaling in tumorigenesis.
Explore frontiers →
Tumor-infiltrating Macrophage Bacterial Sensing and M2 Polarization
Investigation of how tumor-resident bacteria activate pattern recognition receptors on macrophages promoting immunosuppressive M2 phenotype transition.
Explore frontiers →
Respiratory Viral Coinfection and Lung Cancer Progression
Study of influenza and respiratory syncytial virus reactivation in lung cancer tissues and acceleration of tumor growth and metastasis.
Explore frontiers →
Microbial Peptidoglycan and NOD-like Receptor Signaling
Examination of bacterial peptidoglycan fragment translocation and NOD1/NOD2-mediated inflammasome activation in promoting cancer cell proliferation.
Explore frontiers →
Viral miRNA Target Prediction and Cancer Phenotypes
Computational and experimental prediction of oncogenic viral microRNA targets and their contribution to metastatic and drug-resistant phenotypes.
Explore frontiers →
Prevotella copri and Immune Checkpoint Expression Modulation
Investigation of bacteroides-prevotella dysbiosis-associated alterations in PD-1 and PD-L1 expression on lymphocytes and tumor cells.
Explore frontiers →
Bacterial Protease and Tumor Cell Invasiveness Enhancement
Study of microbial serine and metalloproteases degrading extracellular matrix proteins and promoting epithelial-mesenchymal transition in cancer cells.
Explore frontiers →
Human Pegivirus and Hepatocellular Carcinoma Cofactors
Characterization of human pegivirus C persistence and its synergistic oncogenic effects with hepatitis B and C virus in liver cancer.
Explore frontiers →
Microbiota Phage Predation and Bacterial Lysate Oncogenicity
Investigation of bacteriophage-induced bacterial lysis and release of immunogenic and oncogenic microbial components in tumor microenvironments.
Explore frontiers →
Viral Protein Kinase Activities and Cell Cycle Dysregulation
Biochemical characterization of oncogenic viral kinases phosphorylating cyclin-dependent kinase inhibitors and promoting uncontrolled cell cycle progression.
Explore frontiers →
Microbial Metabolite-Driven Epigenetic Remodeling in Cancer
Investigation of how bacterial metabolites alter histone acetylation and DNA methylation patterns promoting oncogene expression and tumor growth.
Explore frontiers →
Tumor-resident Bacteriome and Chemotherapy Drug Metabolism
Study of intratumoral bacterial cytochrome P450 and beta-glucuronidase activity inactivating chemotherapy drugs and promoting treatment failure.
Explore frontiers →
Syncytial Virus Fusion Protein and Cancer Cell Fusion
Investigation of respiratory syncytial virus F protein-mediated multinucleated giant cell formation and enhanced metastatic potential in lung tumors.
Explore frontiers →
Microbial Phytanoyl-CoA Hydroxylase and Lipid Oncosignaling
Analysis of bacterial lipid oxidation enzymes producing signaling lipids activating cancer-promoting membrane receptor pathways.
Explore frontiers →
Epstein Barr Virus Latency Program and B Cell Lymphomas
Comprehensive characterization of viral latency-associated gene expression patterns driving transformation of germinal center B cells to lymphoma.
Explore frontiers →
Microbial Bioactive Lipid A Variants and TLR4 Signaling
Structural identification of bacterial lipopolysaccharide lipid A variants with differential TLR4/MD-2 binding and cancer-promoting inflammatory activity.
Explore frontiers →
Lung Microbiota and Non-small Cell Lung Cancer Outcomes
Prospective study of lower respiratory tract microbiota composition as predictor of overall survival and immunotherapy response in NSCLC.
Explore frontiers →
Bacterial Flagellar Sheath Protein and Immune Escape
Investigation of bacterial flagellar proteins as immunomodulatory antigens promoting regulatory T cell differentiation in tumor-draining lymph nodes.
Explore frontiers →
Respiratory Enteroviruses and Carcinogen Metabolism Alterations
Study of respiratory enterovirus-induced alterations in cytochrome P450 expression modifying polycyclic aromatic hydrocarbon activation and mutagenesis.
Explore frontiers →
Microbial Nucleotide Biosynthesis and Cancer Cell Nucleotide Pools
Investigation of intratumoral bacterial nucleotide synthesis contributing to cancer cell DNA replication and chemotherapy resistance mechanisms.
Explore frontiers →
Viral Long Terminal Repeat Promoter Reactivation in Cancer
Epigenetic analysis of human endogenous retroviral long terminal repeat reactivation and its role in cancer cell oncogene expression.
Explore frontiers →
Candida albicans Hyphal Filaments and Tumor Invasiveness
Examination of fungal pathogen-secreted proteases and cell wall components promoting epithelial invasion and enhanced cancer cell metastatic phenotype.
Explore frontiers →
Microbial Thiosulfate and Sulfur Metabolism in Tumors
Study of intratumoral bacterial sulfur compound metabolism and its effects on reactive oxygen species scavenging and tumor survival.
Explore frontiers →
Rotavirus and Gastric Dysplasia Progression Mechanisms
Investigation of chronic rotavirus infection-induced chronic gastritis and its predisposition to gastric adenocarcinoma development.
Explore frontiers →
Tumor Microbiota and Radiotherapy Toxicity Prediction
Characterization of tumor-associated microbiota composition as biomarker for predicting gastrointestinal toxicity in cancer radiotherapy.
Explore frontiers →
Viral Transformation Assays and Three-dimensional Spheroid Models
Development of organoid and spheroid models recapitulating viral oncogenic transformation in tissue-relevant three-dimensional microenvironments.
Explore frontiers →
Bacterial Cellulose and Biofilm-mediated Immunoevasion
Study of bacterial biofilm exopolysaccharide composition creating physical barriers shielding tumor-resident pathogens from immune recognition.
Explore frontiers →
Microbial-derived Histamine and Cancer Immune Suppression
Investigation of bacterial histidine decarboxylase-mediated histamine production and its role in mast cell-dependent immunosuppression in tumors.
Explore frontiers →
Norovirus and Intestinal Stem Cell Transformation Models
Development of organoid systems studying norovirus infection-induced intestinal epithelial cell transformation and dysplasia progression.
Explore frontiers →
Mycoplasma hyorhinis Transformation and Malignant Conversion
Mechanistic study of how Mycoplasma hyorhinis infection induces cellular transformation and promotes oncogenic phenotypes in various cell types.
Explore frontiers →
Enterotoxigenic Bacteroides fragilis Carcinogenic Pathways
Analysis of ETBF-produced toxins and their molecular mechanisms driving intestinal inflammation and colorectal cancer initiation.
Explore frontiers →
Microbial Sialidase Activity and Mucus Layer Disruption
Examination of bacterial sialidase enzymes in degrading protective mucus barriers and exposing epithelial cells to oncogenic transformation.
Explore frontiers →
Viral Oncoproteins and Ubiquitin-Proteasome System Hijacking
Study of mechanisms by which viral oncoproteins exploit host ubiquitination pathways to degrade tumor suppressors and promote cancer.
Explore frontiers →
Clostridium difficile Toxin-Induced Epithelial Barrier Compromise
Investigation of C. difficile toxin A and B mechanisms in disrupting tight junctions and creating pro-inflammatory cancer microenvironments.
Explore frontiers →
Microbial Lipoproteins and Toll-Like Receptor Signaling Amplification
Characterization of bacterial lipoproteins as TLR agonists and their role in chronic inflammatory signaling supporting tumor development.
Explore frontiers →
HPV E6 and E7 Protein Structural Dynamics and Host Interactions
Molecular dynamics and cryo-EM structural studies of HPV oncoproteins bound to cellular targets for rational therapeutic targeting.
Explore frontiers →
Microbiota-Derived Phenolic Metabolite Aromaticity and AhR Activation
Biochemical analysis of microbial aromatic compound metabolism and consequent aryl hydrocarbon receptor activation in cancer immunity.
Explore frontiers →
Oncogenic Bacteria Horizontal Gene Transfer and Resistance Acquisition
Study of plasmid and chromosomal DNA transfer mechanisms enabling carcinogenic bacteria to acquire fitness advantages in tumor microenvironments.
Explore frontiers →
EBV EBNA and LMP Protein Complex Assembly and Function
Structural and functional characterization of EBV latent antigen complexes and their role in B-cell lymphoma development.
Explore frontiers →
Bacterial Collagenase Production and Extracellular Matrix Remodeling
Mechanistic investigation of microbial matrix metalloproteinase-like enzymes in degrading stromal barriers and facilitating tumor invasion.
Explore frontiers →
Microbiota-Derived Short-Chain Fatty Acid Signaling and Histone Deacetylase Inhibition
Epigenetic analysis of how microbial butyrate and other SCFAs regulate histone acetylation in cancer cells and immune cells.
Explore frontiers →
Viral RNA-Dependent RNA Polymerase Fidelity and Mutation Burden
Biochemical characterization of oncogenic viral polymerase error rates and their contribution to genomic instability in cancer.
Explore frontiers →
Chlamydia trachomatis Chronic Infection and Ovarian Neoplasia
Investigation of persistent Chlamydia infection mechanisms and associated persistent genital inflammation driving ovarian cancer development.
Explore frontiers →
Microbial Heme Acquisition and Iron Metabolism in Tumor Promotion
Analysis of bacterial iron and heme uptake systems in modulating oxidative stress and supporting oncogenic inflammation.
Explore frontiers →
HPV DNA Methylation Patterns and Episomal versus Integrated States
Epigenomic study comparing methylation landscapes of episomal versus chromosomally integrated HPV genomes in cancer progression.
Explore frontiers →
Bacterial Antigenic Mimicry and Cross-Reactive T Cell Activation
Investigation of molecular mimicry between bacterial antigens and self-antigens in breaking immune tolerance during carcinogenesis.
Explore frontiers →
Microbiota Functional Redundancy and Cancer Resistance Phenotypes
Metagenomic and metabolomic characterization of microbial functional equivalence in protective versus pro-tumoral microbiota compositions.
Explore frontiers →
HBV Reverse Transcriptase Processivity and Integration Accuracy
Biochemical analysis of HBV polymerase fidelity and integration preferences near oncogenes in hepatocellular carcinoma development.
Explore frontiers →
Mycobacterium avium subspecies Paratuberculosis and Gastrointestinal Malignancy
Epidemiological and molecular investigation of MAP infection associations with Crohn disease-related gastrointestinal cancer risk.
Explore frontiers →
Bacterial Urease Production and Gastric Epithelial Cell Apoptosis Resistance
Mechanistic study of H. pylori urease-generated ammonia in suppressing epithelial apoptosis and promoting gastric tumorigenesis.
Explore frontiers →
Viral Chromatin Remodeling Complex Recruitment and Epigenetic Hijacking
Investigation of oncogenic viral protein interactions with cellular chromatin remodeling complexes to reprogram cancer cell epigenomes.
Explore frontiers →
Microbiota Estrobolome and Estrogen-Metabolizing Enzyme Expression
Functional characterization of microbial beta-glucuronidase activities in estrogen deconjugation and hormone-dependent cancer promotion.
Explore frontiers →
Capnocytophaga canimorsus and Immunosuppression-Associated Malignancy
Molecular analysis of commensal oral bacteria in promoting opportunistic cancers through immunosuppressive microenvironments.
Explore frontiers →
Acinetobacter baumannii Biofilm Matrix Composition and Tumor Protection
Characterization of polysaccharide biofilm components in shielding cancer cells from immune surveillance and therapeutic agents.
Explore frontiers →
Viral Interferon Antagonism and Type I IFN Signaling Evasion
Molecular study of viral proteins antagonizing interferon production and signaling to establish persistent infection and oncogenic transformation.
Explore frontiers →
Gardnerella vaginalis and Bacterial Vaginosis-Associated Cervical Cancer
Investigation of polymicrobial dysbiosis and Gardnerella-mediated inflammation in increasing cervical cancer susceptibility.
Explore frontiers →
Microbial Polyamine Synthesis and Tumor Cell Proliferation Support
Analysis of bacterial arginine and ornithine metabolism in producing polyamines that support cancer cell growth and division.
Explore frontiers →
JC Polyomavirus Large T Antigen and Cellular Transformation Mechanisms
Functional studies of JCPyV LTag in inactivating p53 and Rb pathways to drive central nervous system malignancies.
Explore frontiers →
Microbiota Bile Acid Metabolism and Farnesoid X Receptor Signaling
Mechanistic investigation of microbial secondary bile acid production and FXR activation in cancer immunity modulation.
Explore frontiers →
Ureaplasma urealyticum Chronic Inflammation and Urogenital Cancer
Study of mycoplasmal glycoprotein-mediated immune activation and its role in chronic genital inflammation and malignant transformation.
Explore frontiers →
Bacterial Vitamin K2 Biosynthesis and Immunoregulation Impact
Biochemical characterization of menaquinone synthesis by commensals and its role in promoting regulatory T cell differentiation.
Explore frontiers →
HCV NS5B Polymerase Structural Variants and Drug Resistance
Cryo-EM and mutagenesis studies of HCV polymerase escape mutations enabling persistent infection and hepatic transformation.
Explore frontiers →
Mycobacterium marinum and Cutaneous Malignancy in Immunocompromised Populations
Investigation of atypical mycobacterial persistence and tissue invasion in promoting cutaneous lymphomas in immune-deficient patients.
Explore frontiers →
Microbial Indole Derivatization and Pregnane X Receptor Activation
Metabolomic and cellular analysis of bacterial indole metabolism in activating nuclear xenobiotic receptors and altering cancer metabolism.
Explore frontiers →
Bacterial Type III Secretion System Effectors and Cellular Signaling Hijacking
Mechanistic studies of pathogenic bacteria T3SS toxins in disrupting Rho signaling and promoting epithelial permeability and transformation.
Explore frontiers →
HTLV-1 Tax Protein Chromatin Recruitment and Clonal Integration Patterns
Genomic and ChIP-seq characterization of HTLV-1 Tax interactions with histone acetyltransferases and preferential integration near oncogenes.
Explore frontiers →
Microbial Metabolite Sensing via G-Protein-Coupled Receptors in Cancer
Functional pharmacology of bacterial metabolite-GPCR interactions in modulating cancer cell survival and immune cell differentiation.
Explore frontiers →
Clostridium perfringens Epsilon Toxin and Gut Barrier Permeability
Mechanism of action studies of C. perfringens toxins in claudin oligomerization and increased intestinal permeability promoting carcinogenesis.
Explore frontiers →
Adenovirus E1A and E1B Viral Oncoproteins in Tumor Suppressor Antagonism
Structural and functional characterization of adenoviral oncoproteins in disrupting p53 and Rb pathways during adenovirus-associated malignancies.
Explore frontiers →
Microbiota Lipopolysaccharide Core Structure Heterogeneity and TLR4 Signaling Variation
Mass spectrometry and immunological profiling of bacterial LPS structural variants and their differential TLR4 activation potency.
Explore frontiers →
Propionibacterium acnes Exotoxin Production and Sebaceous Gland Pathology
Investigation of P. acnes lipase and hyaluronidase in chronic sebaceous inflammation and sebaceous gland carcinoma development.
Explore frontiers →
Viral miRNA Biogenesis Pathway Exploitation and Oncogenic miRNA Generation
Mechanistic study of how oncogenic viruses induce cellular miRNA processing machinery to generate tumor-promoting miRNAs.
Explore frontiers →
Microbiota Glycan Utilization and Mucosal Immunity Development
Genomic and transcriptomic analysis of bacterial carbohydrate-active enzyme repertoires in driving intestinal immunoglobulin A responses.
Explore frontiers →
Bacillus anthracis Lethal Toxin and Macrophage Depletion in Immune Evasion
Study of anthrax toxin-mediated macrophage apoptosis in creating immunosuppressive tumor microenvironments and promoting malignancy.
Explore frontiers →
HCV Core Protein Aggregation and Mitochondrial Dysfunction in Hepatocytes
Cell biology investigation of HCV core protein localization and induction of hepatocyte apoptosis resistance and proliferation.
Explore frontiers →
Bacterial Peptidoglycan Modifications and Immune Tolerance Mechanisms
Structural analysis of pathogenic bacteria cell wall modifications in evading innate immune recognition and promoting immune anergy.
Explore frontiers →
Microbiota Niche Competition and Carcinogen-Metabolizing Bacteria Dominance
Population dynamics modeling of microbial community structure and selection for bacteria with enhanced carcinogen bioactivation capacity.
Explore frontiers →
Microbial Metabolome Profiling and Tumor Immunosuppression
This research category focuses on identifying and characterizing microbial-derived metabolites that directly suppress anti-tumor immune responses through myeloid-derived suppressor cell expansion and regulatory T cell differentiation in the tumor microenvironment.
Explore frontiers →
Human Metapneumovirus and Pediatric Respiratory Malignancy Development
Epidemiological and molecular investigation of hMPV chronic respiratory infection associations with pediatric lung cancer development.
Explore frontiers →
Oncogenic Virus-Host Chromatin Remodeling Dynamics
This category investigates how tumor-associated viruses manipulate host epigenetic machinery and three-dimensional chromatin architecture to silence tumor suppressors and activate oncogenic transcriptional programs during malignant transformation.
Explore frontiers →